Member Info for inanaco

SCIB1-002 trial opened for recruitment in UK and actively screening patients

https://www.scancell.co.uk/Data/Sites/1/media/docspres/agm-2019_all_09sep19.pdf

I refer to ... AGM presentation

""we are active in screening patients ""

I do not know if patients have been treated or not ...

my post was about "is an RNS required"

which is why i asked TF do you have proof its stalled ?

ps

I was referring to the first patient dosed RNS

"""so was I ""

had the debate before with you, hence i indicated pointless to repeat

Its my opinion they don't need to RNS
its your opinion they do ...

seems your like TF ... assuming what i think !!

big mistake

makes no odds chap ... your ability to explain "the average mouse" will fail you again .. but you can try !!

Mousegate 2 ...

TF ... you have no Proof that SCIB1 or 2 is stalled .......

simple ..

if you have show us the data

again ....
what proof have you that its stalled !!!!! ................. I included Immunobody in my reply

so stop deflecting ...

Kat you need to look past SCIB1 ... and what is posted on here ..

Reason Scancell do not have to issue RNS I have mentioned this before ...

I dont want to have this " its what Bio Do" posts again ... (bermuda)

meanwhile if your concerned, consider

Pre-clinical studies have demonstrated that administration of SCIB2 as a liposomal nanoparticle results in potent immune responses and prolonged survival. The nanoparticle technology utilises known lipid carriers that are optimised to deliver SCIB2 DNA to immune cells. The liposomal nanoparticles protect the DNA from degradation and facilitate efficient uptake, expression and T-cell activation against cancer cells. The nanoparticle delivery system provides an alternative approach to electroporation, which has been used to deliver other ImmunoBody agents to patients. Cancer Research UK are now planning a clinical trial to investigate the safety and efficacy of the SCIB2-nanoparticle complex in patients with solid tumours.

Immunobody .... given a green light by one of the Biggest investor in Research in the Country ... £430 Million / year in research !!!

Ichor will be sorted .. but its Ichor that has to sort it ..

again you now claim its stalled .....

what evidence have you that the science has stalled considering

Avidmab is now on the Books
Homocitrulline is now on the books
Mab 2811 is now on the books ...
SCIB1 is in trial
SCIB2 ... in manufacture having cleared Due Diligence
Modi1 ... close to completion of pre-clinical and manufacture
Collaborations on going ...
Modi2 and 3 mentioned in dispatches

what evidence of Stall do you actually have ????

and how can you assume for me ????

TF ....

"disappointed" ......

"""I buy constantly """

Name one other Bio that can potentially treat the majority of cancer ? with a single platform above the normal efficacy rates
of 20 to 30%

Name one other Bio that has controlled a CD4 cytotoxic T cell to a target

why have scientist identified that particular T cell as central to long life ??? ie living over 100 year they carry 4 to 5 x of that particular T cell in the blood stream ??

10 years ago ... I invested at 8p for a single vaccine adjuvant only .... building up a stake of 300,000 shares

Now look what we have !!! ... funny i have more than doubled my holding

your disappointment is because of your own position ... """nothing to do with Scancell"""

otherwise you would not post "the science will see us through"

many poster contradict themselves by this approach ... negativity achieves nothing Ruck considers it a failure ...

yet when asked about what has failed he actually cannot identify anything ...

all he can assume is because no "up front deal" is signed then it must be a failure .. weird logic .... considering he could have exited scancell and moved into a "non failure share" ....

said it many times ......... if you can show what has failed then its open to discussion ...

but its pointless going back to 2015 .... the SCIB1 deal ....... when the market has changed in the adjuvant setting because of Keytruda !!! That window has closed now its "combi" ........ and for that we need the trial results

Drivel ...

I am not holding shares then claiming Scancell has failed ...

I would have sold if i thought that ...

you seem to claim they have failed and you still hold ...

""""A pointless challenge, since most thinking people here realise it is NOT all about the science so please stop inferring it is, it Isn't."""

and you purchased VAL .... Ruck

reason ...

"To Make Money"

good job you ignored the science then Ruck ........ you would be really depressed now !!

PMSL

I take it you have sold your 10p shares Ruck ?

with all that enormous "failed" signal ....

one has to presume your 10p shares took a hit ...

I am not "frustrated at all" ... and certainly i don't need a patronising "calm down" from somebody who cannot string a sentence on the science

As Your mixing up "delay"

with

an enormous gain in understanding ... as its developed ... resulting in an extremely potent vaccine

Scancell has it bang on because the most expensive part is not developing a drug ... ""its Trialing the drug"" that can dwarf any early investment in pre-clinical research ...

and the frustrating part ... bermuda has posted along these lines before i appreciate not to the level that i have, but his base understanding is Far more Clear and of sufficient quality for most shareholders to understand the importance of

1/ Adjuvant polarizing to Th1 (huge gain in efficacy)
2/ Understanding the immune system's suppression of active CD4 T cells
3/The various subsets of Cd4 ... including the latest "long life" forms
4/ discovery of homocitrilline and how the Two vaccines can have synergy ...
4/ MAB 2811 ....

which is why i added that line

"""if somebody could string a sentence on the failure of the science then it would explain "delay" .....

because all delays so far are because of discovery not failure ... and if the market does not see that because its swamped with Mini Moaners ... who are not prepared to study the science in what they are investing in ... makes it a tough call to promote scancell based on what they are actually doing ....

SCIB1 .. is far more complex as it requires a Third party device ...

""" Whatever the reasons, it's doesn't help to mock frustrated shareholders or to somehow suggest that PI's are being unreasonably impatient.""""

RE: Any Time.Today 10:16
if somebody could string a sentence on the failure of the science then it would explain "delay" .....

until that day ...

ATB

The threat here is Not the capital Markets funding Scancells trials ...

Its the capital markets Closing Dec 13th .... if Mao Zedong Red Book opens ....

Crumbs

no they didn't ....

they just signed up to work with lindy .... Genetech, BioNtech, CRUK, ISA Pharma, Avidmab, Karolinska Institutet

How many have signed up with Knowlesi in his "latest project" short term play investments ... ?

if somebody could string a sentence on the failure of the science then it would explain "delay" .....

until that day ...

ATB

Crumbs ., Scancell "invent" .... as such "time scales" can only ever be approx. and the best part

they have never failed in "outcomes" ,..

it seems the ""expected"" ......... get "surpassed" on the stuff that really matters !!!!!!!

moditope from 70% of mice to 100% of mice .. is an example ...